|
Molecular Profiling Honored at 18th Annual Computerworld Honors Laureate Medal Ceremony
Phoenix AZ, June7, 2006- Established in 1988, The Computerworld Honors Program is dedicated to a singular and ongoing mission: "A Search for New Heroes." This search annually identifies and records the accomplishments of the men and women, organizations and institutions that are leading the world's ongoing IT revolution.
In April of 2006, thirty three CIO-level distinguished judges on ten panels- one panel for each of 10 industry categories- completed their review of the case studies submitted by the Computerworld Honors Program's Laureates for the Class of 2006. Based on this review, they named 50 Finalist as guests of honor at ceremonies at the Andrew W. Mellon Auditorium in Washington, D.C. on June 5, 2006. A sample of industry leading organizations in attendance included: BellSouth Corporation, National Cancer Institute (NCI), JP Morgan Chase, Fidelity Investments, Duke University Health System, AOL and Sun Microsystems.
The Molecular Profiling Institute, Phoenix AZ (Molecular Profiling) was selected as one of five finalists for the 2006 21st Century Achievement Award in Medicine for their pioneering work to develop a Clinical Decision Intelligence (CDI) for Cancer Patients.
Molecular Profiling has successfully applied the convergence of information technology, knowledge management, and advanced molecular testing in the health care system to improve quality, individualized care, and provide for choices that are more efficient with our health care dollars. Molecular Profiling's Personalized Medicine Expert System (PerMedEx)™ provides physicians with evidence-based medicine to quickly and accurately apply the latest medical genomic discoveries and best practices to community care.
Presently for late stage cancer patients, PerMedEx integrates the electronic medical record, evidence discovery, clinical rule development and point of care reporting into a single automated process. The solution offers clinicians, providers and payers decision intelligence tools to develop best practices, manage costs and optimize resources. By providing a scalable and secure IT solution Molecular Profiling enables advanced analytics offering insightful patient information and knowledge-based decision tools allowing physicians to deliver high quality, personalized care by optimizing diagnostic, prognostic and treatment decisions.
*********************************
About Molecular Profiling- Molecular Profiling is a CLIA certified specialty reference laboratory that helps patients by applying the discoveries of the human genome project to personalized medicine. Molecular Profiling provides cutting-edge testing facilities, prognostic testing services, and resources for genomic and proteomic profiling and treatment of cancer and other complex diseases. The underlying cause of each patient's disease is typically unique to the individual and Molecular Profiling provides advanced analysis and tools to better help the physician determine the molecular characteristics of each patient's disease so that they may better tailor a more effective medical strategy specific to the individual.
Contact
Robert Penny, MD, PhD
(602) 358-8901
rpenny@molecularprofiling.com
|
|
|
|
